GlaxoSmithKline Plc, the U.K.’s largest drugmaker, will pay $105 million to settle claims by California, New York and more than 40 other states that it illegally promoted asthma and antidepressant drugs.
Maryland has recovered $15 million from drug maker GlaxoSmithKline LLC to resolve allegations that the company engaged in improper marketing of the prescription drugs Avandia, Avandamet and Avandaryl, all of which are used to treat diabetes.
Should general counsels be indicted by the government in investigations into company practices?
What are the main reasons you would fire outside counsel or have fired outside counsel in the past?
ROCKVILLE — Rockville-based Human Genome Sciences says it will be cutting 114 jobs. The company told state regulators that it was undergoing an internal restructuring that will lead to the cuts at the end of October. British drug maker GlaxoSmithKline announced in July that it was acquiring the longtime partner in a $3.6 billion deal. […]
DOVER, Del. — A federal judge in Delaware has refused to issue a restraining order delaying the acquisition of Human Genome Sciences Inc. by GlaxoSmithKline. Two HGS shareholders had argued that the tender offer period should be extended beyond Friday’s deadline because Glaxo’s agreement last week to pay $14.25 a share represented a new deal […]
U.K. drug maker GlaxoSmithKline has secured its takeover of longtime partner Human Genome Sciences after agreeing to pay more, a move to expand GSK’s drug portfolio in crucial areas: biologic drugs and treatments for the hundreds of millions of people with diabetes and heart disease. The two companies said Monday that GSK will pay $3.6 […]
It’s all about in-house education this week. Asked: Our weekly question to the In-House community Most law schools don’t have classes that specifically prepare attorneys for jobs as in-house counsels. And in today’s unsteady economy, more law students are thinking of going directly into in-house careers, a trend we reported among Maryland schools in May. […]
WASHINGTON — GlaxoSmithKline LLC will pay $3 billion and plead guilty to promoting two popular drugs for unapproved uses and to failing to disclose important safety information on a third in the largest health care fraud settlement in U.S. history, the Justice Department said Monday. Accompanying the criminal case was a civil settlement in which […]
WASHINGTON — The Supreme Court has ruled that sales representatives for pharmaceutical companies do not qualify for overtime pay under federal law, a big victory for the drug industry. In a 5-4 decision Monday, the court’s conservative majority concluded that the roughly 90,000 people who try to persuade doctors to prescribe certain drugs to their […]
Human Genome Sciences Inc. entered into confidentiality agreements with “certain parties” and is providing an opportunity to engage in due diligence reviews, the Rockville-based company said Thursday. Its board of directors unanimously said shareholders should reject an “inadequate” $2.6 billion bid from British pharmaceutical giant GlaxoSmithKline plc. Glaxo said on May 9 it would commenc[...]
The decision by Rockville-based biotech drugmaker Human Genome Sciences Inc. to reject an unsolicited $2.59 billion takeover bid Thursday may increase the eventual sale price of the company, analysts said. The question is by how much. “For the most part, we think it’s a fair offer,” said Lauren Migliore, an equity analyst with Chicago-based Morningstar. […]